{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:09:51Z","timestamp":1753891791555,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The impact of weight loss and\/or improved metabolic status on the risk of non-alcoholic fatty liver disease (NAFLD) has yet to be determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 35,322 participants without NAFLD were followed. NAFLD risk was compared between consistently metabolically healthy non-obese (MHNO) and non-MHNO who lost weight to become non-obese and\/or improved their metabolic health, using Cox proportional hazards and logistic regression models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Following 148,186 person-years, 8,409 participants had onset NAFLD, with an incidence rate of 56.75 (95% CI: 55.57, 57.94) per 1,000 person-years. Metabolically healthy obese (MHO), metabolically unhealthy obese (MUO), and metabolically unhealthy non-obese (MUNO) at baseline were associated with increased NAFLD risk, with hazard ratios of 4.48 (95%CI:4.24, 4.73), 8.85 (95%CI:7.95, 9.84), and 10.70 (95%CI:9.73, 11.78). Weight loss and\/or metabolic status improvements could significantly reduce NAFLD risk by 79.46 to 41.46%. Specifically, after weight loss from MHO to MHNO, the reduction in NAFLD risk [OR decreased from 12.01 (95%CI:9.40, 15.35) to 4.14 (95%CI:3.08, 5.57)] was greater than that of the MUNO subgroup whose metabolic status improved to MHNO [OR decreased from 5.53 (95%CI:5.15, 5.94) to 2.71 (95%CI:2.50, 3.93)]. In the MUO subgroup, the group with the greatest risk reduction of NAFLD was the weight and metabolic state both improvement group [MUO to MHNO, OR decreased from 22.74 (95%CI:17.61, 29.37) to 4.67 (95%CI:3.05, 7.16)], followed by the weight loss only group [MUO to MUNO, OR decreased to 6.83 (95%CI:4.87, 9.57)], and finally the group with the least and insignificant risk reduction was the metabolic state improvement group [MUO to MHO, OR decreased to 13.38 (95%CI:9.17,19.53)]. NAFLD risk was negatively correlated with the duration of improvement (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Individuals with non-MHNO were more likely to develop NAFLD than those with consistent MHNO, but metabolic improvements and weight loss can alleviate the risk. Their NAFLD risk was negatively correlated with improvement duration. However, it remained higher than in individuals with consistent MHNO at an average follow-up of 4.2\u2009years.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2023.1239996","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T09:40:45Z","timestamp":1701164445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The effects of weight loss and improved metabolic health status on the risk of non-alcoholic fatty liver disease\u2014results from a prospective cohort in China"],"prefix":"10.3389","volume":"10","author":[{"given":"Xin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.7326\/m15-1323","article-title":"Metabolically healthy obesity and development of chronic kidney disease","volume":"164","author":"Chang","year":"2016","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/cld.722","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"11","year":"2018","journal-title":"Clin Liver Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/s2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/s2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/s2213-8587(23)00086-4","article-title":"Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment","volume":"11","author":"Stefan","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","article-title":"AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions","volume":"49","author":"Lonardo","year":"2017","journal-title":"Dig Liver Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/hepr.12656","article-title":"The independent predictors of non-alcoholic steatohepatitis and its individual histological features","volume":"46","author":"Ballestri","year":"2016","journal-title":"Hepatol Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/s2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1136\/gutjnl-2018-317666","article-title":"Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung health study","volume":"68","author":"Chang","year":"2018","journal-title":"Gut"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ajg.2016.178","article-title":"Metabolically healthy obesity and the development of nonalcoholic fatty liver disease","volume":"111","author":"Chang","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12902-020-00582-9","article-title":"Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): a United Kingdom population-based cohort study using the health improvement network (THIN)","volume":"20","author":"Vusirikala","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/s1590-8658(02)80111-6","article-title":"Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild\/moderate abnormalities of liver transaminases","volume":"34","author":"Mathiesen","year":"2002","journal-title":"Dig Liver Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1016\/j.cgh.2021.04.037","article-title":"Weight change and the development of nonalcoholic fatty liver disease in metabolically healthy overweight individuals","volume":"20","author":"Cho","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"11244","DOI":"10.3389\/fnut.2021.811244","article-title":"Trends in obesity and metabolic status in northern and southern China between 2012 and 2020. Frontiers","volume":"8","author":"Li","year":"2022","journal-title":"Nutrition"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.hbpd.2020.02.010","article-title":"Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese","volume":"19","author":"Wu","year":"2020","journal-title":"Hepatobiliary Pancreat Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.pcad.2018.07.008","article-title":"Role of physical activity and fitness in the characterization and prognosis of the metabolically healthy obesity phenotype: a systematic review and meta-analysis","volume":"61","author":"Ortega","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/s2213-8587(18)30137-2","article-title":"Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90\u2008257 women (the nurses\u2019 health study): 30 year follow-up from a prospective cohort study","volume":"6","author":"Eckel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1017\/s136898002000289x","article-title":"BMI, high-sensitivity C-reactive protein and the conversion from metabolically healthy to unhealthy phenotype in Chinese adults: a cohort study","volume":"24","author":"Xu","year":"2020","journal-title":"Public Health Nutr"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/oby.22536","article-title":"Association between nonalcoholic fatty liver disease and future deterioration of metabolic health: a cohort study","volume":"27","author":"Hwang","year":"2019","journal-title":"Obesity"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s12872-021-02279-w","article-title":"Transition from metabolically healthy to unhealth status associated with risk of carotid artery plaque in Chinese adults","volume":"21","author":"Tan","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13293-018-0205-7","article-title":"Tissue-specific pathways and networks underlying sexual dimorphism in non-alcoholic fatty liver disease","volume":"9","author":"Kurt","year":"2018","journal-title":"Biol Sex Differ"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fphys.2018.00360","article-title":"LiverSex computational model: sexual aspects in hepatic metabolism and abnormalities","volume":"9","author":"Cvitanovi\u0107 Toma\u0161","year":"2018","journal-title":"Front Physiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/ijo.2010.106","article-title":"Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16\u2009390 overweight or obese children and adolescents","volume":"34","author":"Wiegand","year":"2010","journal-title":"Int J Obes"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1210\/jc.2004-0165","article-title":"Metabolic and body composition factors in subgroups of obesity: what do we know?","volume":"89","author":"Karelis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/ajcn\/85.1.40","article-title":"Normal-weight obese syndrome: early inflammation?","volume":"85","author":"De Lorenzo","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.2337\/diacare.26.8.2341","article-title":"Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, Normal weight subjects with Normal glucose tolerance","volume":"26","author":"Katsuki","year":"2003","journal-title":"Diabetes Care"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/eurheartj\/ehp487","article-title":"Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality","volume":"31","author":"Romero-Corral","year":"2009","journal-title":"Eur Heart J"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1210\/jc.2013-2832","article-title":"Risk of developing diabetes and cardiovascular disease in metabolically unhealthy Normal-weight and metabolically healthy obese individuals","volume":"99","author":"Aung","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/s2213-8587(20)30110-8","article-title":"Causes, consequences, and treatment of metabolically unhealthy fat distribution","volume":"8","author":"Stefan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jhep.2023.01.024","article-title":"An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease","volume":"78","author":"Lee","year":"2023","journal-title":"J Hepatol"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1239996\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T09:40:48Z","timestamp":1701164448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1239996\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":37,"alternative-id":["10.3389\/fnut.2023.1239996"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2023.1239996","relation":{},"ISSN":["2296-861X"],"issn-type":[{"type":"electronic","value":"2296-861X"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"article-number":"1239996"}}